Recombinomics | Elegant Evolution

Home Founder What's New In The News Contact Us

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies


17th H5N1 Fatality Dies 4.5 Hours After Re-Admission

Recombinomics Commentary

October 12, 2005

The first child from nine related this could be permitted to come home to rumah.Winaa died around 4.5 hours after being brought returned to the Infection Hospital (RSPI) Sulianti Saroso, Sunter, Jakarta North.

Vienna was permitted to come home to last October 4. Vienna has at that time been stated free from the affected assumption of the virus of birds flu. Results of the inspection showed he only was affected by the inflammation of the lungs.

The above machine translation describes Vienna Eka Defianti who had been hospitalized between September 22 and October 4 because of bird flu symptoms.  After release, she had a relapse and entered RS Friendship and was transferred to Sulianti Saroso, where she died 4.5 hours later.

On Sunday another transfer died 20 minutes after admission.

The transfers of these patients raise serious questions about Indonesia's care and testing of these patients.  Most patients initially are admitted into primary care facilities where they are not tested for bird flu.  When the patients fail to recover, Jakarta patients are transferred to Sulianti Saroso, where they are testted, but H5N1 has moved to the lungs, so the nose and throat swabs are negative

The two most recent deaths happened within 5 hours of transfer.

These patients are not placed on the list of suspect bird flu cases until they are admitted to the infectious disease hospitals.  It is unclear why the transfers are just prior to death, but the relationship between the transfer and placement on the suspect bird flu list needs clarification.

Similarly, the discharge of patients who die 8 days later is also a concern.  Both early release and late admission reduce the number of patients under treatment at the infectious disease hospital.  These two recent deaths raise serious questions on how suspect bird flu patients are being monitored and treated.

Monitoring of H5N1 remains scandalously poor.


Media Resources

Home | Founder | What's New | In The News | Contact Us

© 2005 Recombinomics.  All rights reserved.